In the clinical data, the LMO2 expression level and pY705-STAT3 reverse-phase protein array score were positively correlated in the TCGA GBMLGG (Low-grade glioma) dataset (Supplementary Figure S1D). This evidence concerns the gene LMO2 and central nervous system cancer.